Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-29 @ 11:59 AM
Study NCT ID:
NCT00069992
Status:
TERMINATED
Last Update Posted:
2012-10-10
First Post:
2003-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
Sponsor:
Baylor College of Medicine
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
H-10857-MPDMDSBMT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None